NCT02182778View on ClinicalTrials.gov

GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

July 9, 2014

Primary Completion Date

February 4, 2016

Study Completion Date

April 16, 2018

Conditions
Biliary Tract Cancer
Interventions
DRUG

Gemcitabine/Cisplatin

Gemcitabine and cisplatin are infused on day1, 8. The cycle is repeated every 3 weeks.

DRUG

Gemcitabine/Cisplatin /S-1

S-1 is given daily for 7 consecutive days and gemcitabine and cisplatin are infused on day1. The cycle is repeated every 2 weeks.

Trial Locations (1)

606-8507

Kyoto University Hospital, Kyoto

All Listed Sponsors
lead

Kansai Hepatobiliary Oncology Group

NETWORK

NCT02182778 - GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer | Biotech Hunter | Biotech Hunter